Structure

Physi-Chem Properties

Molecular Weight:  384.12
Volume:  383.906
LogP:  3.148
LogD:  2.499
LogS:  -3.526
# Rotatable Bonds:  4
TPSA:  113.29
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.687
Synthetic Accessibility Score:  4.42
Fsp3:  0.238
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.053
MDCK Permeability:  2.0256362404325046e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.174
Human Intestinal Absorption (HIA):  0.347
20% Bioavailability (F20%):  0.987
30% Bioavailability (F30%):  0.883

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.279
Plasma Protein Binding (PPB):  90.54779815673828%
Volume Distribution (VD):  1.246
Pgp-substrate:  7.153619289398193%

ADMET: Metabolism

CYP1A2-inhibitor:  0.97
CYP1A2-substrate:  0.364
CYP2C19-inhibitor:  0.646
CYP2C19-substrate:  0.071
CYP2C9-inhibitor:  0.77
CYP2C9-substrate:  0.798
CYP2D6-inhibitor:  0.943
CYP2D6-substrate:  0.115
CYP3A4-inhibitor:  0.88
CYP3A4-substrate:  0.253

ADMET: Excretion

Clearance (CL):  4.779
Half-life (T1/2):  0.67

ADMET: Toxicity

hERG Blockers:  0.036
Human Hepatotoxicity (H-HT):  0.966
Drug-inuced Liver Injury (DILI):  0.793
AMES Toxicity:  0.966
Rat Oral Acute Toxicity:  0.976
Maximum Recommended Daily Dose:  0.964
Skin Sensitization:  0.921
Carcinogencity:  0.922
Eye Corrosion:  0.005
Eye Irritation:  0.741
Respiratory Toxicity:  0.921

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472891

Natural Product ID:  NPC472891
Common Name*:   [(7S,8S)-7-Hydroxy-7-Methyl-6-Oxo-3-[(E)-Prop-1-Enyl]-8H-Isochromen-8-Yl] 2,4-Dihydroxy-6-Methylbenzoate
IUPAC Name:   [(7S,8S)-7-hydroxy-7-methyl-6-oxo-3-[(E)-prop-1-enyl]-8H-isochromen-8-yl] 2,4-dihydroxy-6-methylbenzoate
Synonyms:  
Standard InCHIKey:  SYFXCPIQIAFGIJ-PXODQFSGSA-N
Standard InCHI:  InChI=1S/C21H20O7/c1-4-5-14-7-12-8-17(24)21(3,26)19(15(12)10-27-14)28-20(25)18-11(2)6-13(22)9-16(18)23/h4-10,19,22-23,26H,1-3H3/b5-4+/t19-,21+/m0/s1
SMILES:  C/C=C/C1=CC2=CC(=O)[C@@]([C@H](C2=CO1)OC(=O)c1c(C)cc(cc1O)O)(C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3593566
PubChem CID:   44225039
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000176] Benzoic acids and derivatives
          • [CHEMONTID:0001350] Benzoic acid esters
            • [CHEMONTID:0004701] p-Hydroxybenzoic acid esters
              • [CHEMONTID:0004702] p-Hydroxybenzoic acid alkyl esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33444 penicillium pinophilum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22264170]
NPO33336 Penicillium sp. HN29-3B1 Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26230970]
NPO33444 penicillium pinophilum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26291474]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT60 Individual Protein Lysosomal alpha-glucosidase Homo sapiens IC50 = 16600.0 nM PMID[523015]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472891 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9862 High Similarity NPC115249
0.9862 High Similarity NPC184284
0.9862 High Similarity NPC478224
0.9862 High Similarity NPC76041
0.9795 High Similarity NPC137301
0.9728 High Similarity NPC472890
0.9728 High Similarity NPC69043
0.9728 High Similarity NPC208173
0.9728 High Similarity NPC478230
0.9728 High Similarity NPC170189
0.966 High Similarity NPC478231
0.9597 High Similarity NPC472889
0.9597 High Similarity NPC478225
0.9595 High Similarity NPC478221
0.9595 High Similarity NPC317585
0.9521 High Similarity NPC84142
0.9467 High Similarity NPC246466
0.9467 High Similarity NPC478226
0.9456 High Similarity NPC164762
0.9392 High Similarity NPC91809
0.9281 High Similarity NPC317544
0.9252 High Similarity NPC210320
0.9236 High Similarity NPC158634
0.9226 High Similarity NPC191930
0.9189 High Similarity NPC215711
0.9189 High Similarity NPC73411
0.9167 High Similarity NPC158472
0.9161 High Similarity NPC249181
0.9161 High Similarity NPC478200
0.9161 High Similarity NPC33144
0.9145 High Similarity NPC472050
0.9139 High Similarity NPC471695
0.911 High Similarity NPC478202
0.9108 High Similarity NPC283041
0.9097 High Similarity NPC268052
0.9097 High Similarity NPC32360
0.9097 High Similarity NPC247409
0.9048 High Similarity NPC280404
0.9048 High Similarity NPC210425
0.9048 High Similarity NPC277426
0.9048 High Similarity NPC86373
0.9045 High Similarity NPC20237
0.9028 High Similarity NPC191835
0.9 High Similarity NPC4423
0.9 High Similarity NPC237440
0.9 High Similarity NPC77325
0.9 High Similarity NPC270160
0.8973 High Similarity NPC472035
0.8973 High Similarity NPC313123
0.8973 High Similarity NPC478201
0.8973 High Similarity NPC478217
0.8973 High Similarity NPC53649
0.8973 High Similarity NPC244923
0.8966 High Similarity NPC52358
0.8958 High Similarity NPC70380
0.894 High Similarity NPC56204
0.8931 High Similarity NPC328321
0.8926 High Similarity NPC473023
0.8919 High Similarity NPC42540
0.8919 High Similarity NPC151607
0.8912 High Similarity NPC474385
0.8912 High Similarity NPC82913
0.891 High Similarity NPC117985
0.8903 High Similarity NPC470339
0.8897 High Similarity NPC94248
0.8897 High Similarity NPC472602
0.8897 High Similarity NPC212693
0.8889 High Similarity NPC235115
0.8882 High Similarity NPC70016
0.8882 High Similarity NPC215921
0.8881 High Similarity NPC175943
0.8859 High Similarity NPC472034
0.8859 High Similarity NPC83272
0.8851 High Similarity NPC159721
0.8851 High Similarity NPC472006
0.8846 High Similarity NPC472055
0.8844 High Similarity NPC67650
0.8844 High Similarity NPC475730
0.8844 High Similarity NPC1704
0.8844 High Similarity NPC472603
0.8836 High Similarity NPC92655
0.8831 High Similarity NPC99381
0.8828 High Similarity NPC71256
0.8811 High Similarity NPC153783
0.8808 High Similarity NPC240253
0.8808 High Similarity NPC471641
0.8808 High Similarity NPC471642
0.8808 High Similarity NPC240622
0.88 High Similarity NPC472033
0.8792 High Similarity NPC210966
0.8792 High Similarity NPC478203
0.8792 High Similarity NPC126882
0.8776 High Similarity NPC472601
0.8776 High Similarity NPC155205
0.8776 High Similarity NPC156872
0.8776 High Similarity NPC472600
0.8767 High Similarity NPC9121
0.8767 High Similarity NPC177307
0.8758 High Similarity NPC200773
0.8758 High Similarity NPC240768
0.8758 High Similarity NPC46882
0.8758 High Similarity NPC132990
0.8742 High Similarity NPC472036
0.8733 High Similarity NPC257558
0.8733 High Similarity NPC312789
0.8725 High Similarity NPC469542
0.8725 High Similarity NPC471731
0.8725 High Similarity NPC51106
0.8716 High Similarity NPC472604
0.8716 High Similarity NPC472605
0.871 High Similarity NPC471456
0.8707 High Similarity NPC139634
0.8707 High Similarity NPC105456
0.8701 High Similarity NPC470340
0.8701 High Similarity NPC167903
0.8699 High Similarity NPC474849
0.8699 High Similarity NPC178467
0.8699 High Similarity NPC474771
0.8699 High Similarity NPC135837
0.8699 High Similarity NPC149372
0.8699 High Similarity NPC65837
0.8693 High Similarity NPC469619
0.8693 High Similarity NPC158866
0.8693 High Similarity NPC469670
0.869 High Similarity NPC27407
0.8684 High Similarity NPC37139
0.8684 High Similarity NPC94781
0.8675 High Similarity NPC107625
0.8671 High Similarity NPC219892
0.8671 High Similarity NPC189823
0.8667 High Similarity NPC475201
0.8667 High Similarity NPC103910
0.8667 High Similarity NPC257025
0.8658 High Similarity NPC471733
0.8658 High Similarity NPC250755
0.8658 High Similarity NPC469579
0.8658 High Similarity NPC322112
0.8654 High Similarity NPC227062
0.8645 High Similarity NPC472799
0.8645 High Similarity NPC155686
0.8645 High Similarity NPC192189
0.8639 High Similarity NPC475974
0.8639 High Similarity NPC197666
0.8639 High Similarity NPC126739
0.8639 High Similarity NPC472403
0.8636 High Similarity NPC205918
0.8634 High Similarity NPC473094
0.863 High Similarity NPC50455
0.8627 High Similarity NPC280753
0.8627 High Similarity NPC476684
0.8627 High Similarity NPC44378
0.8618 High Similarity NPC166583
0.8618 High Similarity NPC81835
0.8618 High Similarity NPC259632
0.8618 High Similarity NPC476463
0.8618 High Similarity NPC53362
0.86 High Similarity NPC354984
0.86 High Similarity NPC472610
0.86 High Similarity NPC21873
0.8599 High Similarity NPC473395
0.8591 High Similarity NPC130485
0.859 High Similarity NPC56786
0.859 High Similarity NPC79998
0.859 High Similarity NPC16082
0.859 High Similarity NPC80534
0.859 High Similarity NPC237560
0.859 High Similarity NPC82592
0.859 High Similarity NPC473241
0.8581 High Similarity NPC88269
0.8581 High Similarity NPC113608
0.8581 High Similarity NPC268992
0.8581 High Similarity NPC256141
0.8581 High Similarity NPC51824
0.8581 High Similarity NPC470337
0.8581 High Similarity NPC295339
0.8581 High Similarity NPC470338
0.858 High Similarity NPC473096
0.858 High Similarity NPC472619
0.858 High Similarity NPC473095
0.8571 High Similarity NPC261292
0.8571 High Similarity NPC150928
0.8571 High Similarity NPC179178
0.8571 High Similarity NPC194579
0.8571 High Similarity NPC301915
0.8571 High Similarity NPC295036
0.8571 High Similarity NPC85131
0.8571 High Similarity NPC180351
0.8562 High Similarity NPC180905
0.8562 High Similarity NPC221352
0.8562 High Similarity NPC182496
0.8562 High Similarity NPC142027
0.8553 High Similarity NPC51513
0.8553 High Similarity NPC163846
0.8553 High Similarity NPC260946
0.8553 High Similarity NPC202112
0.8553 High Similarity NPC112418
0.8553 High Similarity NPC225173
0.8544 High Similarity NPC280680
0.8544 High Similarity NPC477410
0.8543 High Similarity NPC95123

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472891 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8707 High Similarity NPD970 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD7075 Discontinued
0.8471 Intermediate Similarity NPD3817 Phase 2
0.8421 Intermediate Similarity NPD6799 Approved
0.8408 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6801 Discontinued
0.8333 Intermediate Similarity NPD6599 Discontinued
0.8291 Intermediate Similarity NPD7819 Suspended
0.8247 Intermediate Similarity NPD2532 Approved
0.8247 Intermediate Similarity NPD2534 Approved
0.8247 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8247 Intermediate Similarity NPD2533 Approved
0.8228 Intermediate Similarity NPD1934 Approved
0.8217 Intermediate Similarity NPD4380 Phase 2
0.8194 Intermediate Similarity NPD1512 Approved
0.8187 Intermediate Similarity NPD3882 Suspended
0.8176 Intermediate Similarity NPD2801 Approved
0.8176 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6232 Discontinued
0.8141 Intermediate Similarity NPD5403 Approved
0.8133 Intermediate Similarity NPD1510 Phase 2
0.8125 Intermediate Similarity NPD5402 Approved
0.8121 Intermediate Similarity NPD7473 Discontinued
0.8105 Intermediate Similarity NPD3750 Approved
0.8065 Intermediate Similarity NPD1511 Approved
0.8061 Intermediate Similarity NPD6166 Phase 2
0.8061 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD6797 Phase 2
0.8026 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD5401 Approved
0.7988 Intermediate Similarity NPD7251 Discontinued
0.7974 Intermediate Similarity NPD1549 Phase 2
0.7961 Intermediate Similarity NPD2796 Approved
0.7941 Intermediate Similarity NPD7808 Phase 3
0.7933 Intermediate Similarity NPD230 Phase 1
0.7917 Intermediate Similarity NPD7054 Approved
0.7917 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD1607 Approved
0.7879 Intermediate Similarity NPD6959 Discontinued
0.7871 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD7472 Approved
0.7867 Intermediate Similarity NPD1240 Approved
0.7861 Intermediate Similarity NPD8150 Discontinued
0.7857 Intermediate Similarity NPD3818 Discontinued
0.7853 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD7411 Suspended
0.7811 Intermediate Similarity NPD5844 Phase 1
0.7805 Intermediate Similarity NPD3749 Approved
0.7791 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3748 Approved
0.7765 Intermediate Similarity NPD7074 Phase 3
0.7756 Intermediate Similarity NPD4628 Phase 3
0.7727 Intermediate Similarity NPD1551 Phase 2
0.7707 Intermediate Similarity NPD6190 Approved
0.7674 Intermediate Similarity NPD6559 Discontinued
0.7651 Intermediate Similarity NPD919 Approved
0.7647 Intermediate Similarity NPD3751 Discontinued
0.7643 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD7768 Phase 2
0.7633 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD943 Approved
0.7619 Intermediate Similarity NPD5710 Approved
0.7619 Intermediate Similarity NPD5711 Approved
0.7616 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD2935 Discontinued
0.761 Intermediate Similarity NPD7390 Discontinued
0.7569 Intermediate Similarity NPD9545 Approved
0.7515 Intermediate Similarity NPD1465 Phase 2
0.7515 Intermediate Similarity NPD3787 Discontinued
0.75 Intermediate Similarity NPD3764 Approved
0.75 Intermediate Similarity NPD5404 Approved
0.75 Intermediate Similarity NPD6100 Approved
0.75 Intermediate Similarity NPD5406 Approved
0.75 Intermediate Similarity NPD5408 Approved
0.75 Intermediate Similarity NPD5494 Approved
0.75 Intermediate Similarity NPD6099 Approved
0.75 Intermediate Similarity NPD5405 Approved
0.7485 Intermediate Similarity NPD3226 Approved
0.7472 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD2800 Approved
0.7459 Intermediate Similarity NPD7435 Discontinued
0.7458 Intermediate Similarity NPD8434 Phase 2
0.744 Intermediate Similarity NPD6234 Discontinued
0.7431 Intermediate Similarity NPD9493 Approved
0.7419 Intermediate Similarity NPD6651 Approved
0.7403 Intermediate Similarity NPD6535 Approved
0.7403 Intermediate Similarity NPD6534 Approved
0.7401 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD6776 Approved
0.7391 Intermediate Similarity NPD6779 Approved
0.7391 Intermediate Similarity NPD6777 Approved
0.7391 Intermediate Similarity NPD6780 Approved
0.7391 Intermediate Similarity NPD6781 Approved
0.7391 Intermediate Similarity NPD6778 Approved
0.7391 Intermediate Similarity NPD6782 Approved
0.7365 Intermediate Similarity NPD1201 Approved
0.7362 Intermediate Similarity NPD920 Approved
0.7362 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD1243 Approved
0.7353 Intermediate Similarity NPD7199 Phase 2
0.7349 Intermediate Similarity NPD37 Approved
0.7342 Intermediate Similarity NPD2346 Discontinued
0.7329 Intermediate Similarity NPD3300 Phase 2
0.7329 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD8320 Phase 1
0.7326 Intermediate Similarity NPD8319 Approved
0.7325 Intermediate Similarity NPD7033 Discontinued
0.7322 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD4966 Approved
0.7321 Intermediate Similarity NPD4965 Approved
0.7321 Intermediate Similarity NPD4967 Phase 2
0.729 Intermediate Similarity NPD4060 Phase 1
0.7288 Intermediate Similarity NPD8313 Approved
0.7288 Intermediate Similarity NPD8312 Approved
0.7285 Intermediate Similarity NPD1470 Approved
0.7283 Intermediate Similarity NPD7700 Phase 2
0.7283 Intermediate Similarity NPD7699 Phase 2
0.7273 Intermediate Similarity NPD6798 Discontinued
0.7267 Intermediate Similarity NPD3926 Phase 2
0.7251 Intermediate Similarity NPD1247 Approved
0.7248 Intermediate Similarity NPD422 Phase 1
0.7244 Intermediate Similarity NPD6355 Discontinued
0.7244 Intermediate Similarity NPD447 Suspended
0.7239 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7874 Approved
0.7216 Intermediate Similarity NPD5953 Discontinued
0.7215 Intermediate Similarity NPD2799 Discontinued
0.7205 Intermediate Similarity NPD8166 Discontinued
0.72 Intermediate Similarity NPD9717 Approved
0.72 Intermediate Similarity NPD9269 Phase 2
0.7192 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD7697 Approved
0.7181 Intermediate Similarity NPD7698 Approved
0.7181 Intermediate Similarity NPD7696 Phase 3
0.7178 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD8151 Discontinued
0.7171 Intermediate Similarity NPD1203 Approved
0.7169 Intermediate Similarity NPD7458 Discontinued
0.7169 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD3268 Approved
0.7161 Intermediate Similarity NPD411 Approved
0.716 Intermediate Similarity NPD4288 Approved
0.7143 Intermediate Similarity NPD6832 Phase 2
0.7143 Intermediate Similarity NPD7870 Phase 2
0.7143 Intermediate Similarity NPD7871 Phase 2
0.7143 Intermediate Similarity NPD7228 Approved
0.7143 Intermediate Similarity NPD1652 Phase 2
0.7135 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5124 Phase 1
0.7126 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD2798 Approved
0.712 Intermediate Similarity NPD7701 Phase 2
0.7115 Intermediate Similarity NPD6233 Phase 2
0.7108 Intermediate Similarity NPD1653 Approved
0.7107 Intermediate Similarity NPD4308 Phase 3
0.7102 Intermediate Similarity NPD7286 Phase 2
0.7079 Intermediate Similarity NPD7685 Pre-registration
0.7059 Intermediate Similarity NPD2797 Approved
0.7051 Intermediate Similarity NPD2313 Discontinued
0.7047 Intermediate Similarity NPD9268 Approved
0.7039 Intermediate Similarity NPD4749 Approved
0.7037 Intermediate Similarity NPD2654 Approved
0.703 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD2403 Approved
0.7025 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD5762 Approved
0.7019 Intermediate Similarity NPD2344 Approved
0.7019 Intermediate Similarity NPD5763 Approved
0.7012 Intermediate Similarity NPD7236 Approved
0.7011 Intermediate Similarity NPD7229 Phase 3
0.701 Intermediate Similarity NPD7783 Phase 2
0.701 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7801 Approved
0.7 Intermediate Similarity NPD4626 Approved
0.6994 Remote Similarity NPD7003 Approved
0.6988 Remote Similarity NPD6273 Approved
0.6987 Remote Similarity NPD7095 Approved
0.6987 Remote Similarity NPD4625 Phase 3
0.6987 Remote Similarity NPD3027 Phase 3
0.6974 Remote Similarity NPD1608 Approved
0.6968 Remote Similarity NPD9494 Approved
0.6962 Remote Similarity NPD1613 Approved
0.6962 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6959 Remote Similarity NPD5353 Approved
0.6957 Remote Similarity NPD2438 Suspended
0.6951 Remote Similarity NPD3887 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data